CHOP’s Hemostasis and Thrombosis Center Celebrates 50th Anniversary
Published on

A look back at the last five decades of treatment options to what lies ahead with additional potentially curative gene therapies.
Published on
A look back at the last five decades of treatment options to what lies ahead with additional potentially curative gene therapies.
Published on
CHOP gene therapy expert Dr. Lindsey George reacts to a phase 3 hemophilia gene therapy study in an editorial in the New England Journal of Medicine.
Published on
The Novel Therapeutics for Bleeding Disorders (NoT Bleeding) Program is a Children’s Hospital of Philadelphia (CHOP) Frontier Program within the Division of Hematology that aims to provide advanced clinical care of inherited bleeding disorders and develop breakthrough treatments through research.
Published on
CHOP experts in bleeding disorders care and research presented at the American Society of Hematology 2022 conference.